Haptoglobin genotype is a determinant of survival and cardiac remodeling after myocardial infarction in diabetic mice

Cardiovascular Diabetology

Volumn 8, Issue , 2009, Pages

  Blum, Shany ^a   Roguin, Ariel ^a   Kalet Litman, Shiri ^a,b   Kheir, Jad ^a   Frisch, Avi ^a   Miller Lotan, Rachel ^a   Levy, Andrew P ^a   Asaf, Roy ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Department of Cardiology ^*  (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; HAPTOGLOBIN; STREPTOZOCIN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE INSERTION; GENE LOCUS; GENOTYPE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HOMOLOGOUS RECOMBINATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MORTALITY; MOUSE; NONHUMAN; STREPTOZOCIN DIABETES; SURVIVAL RATE; TRANSTHORACIC ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WILD TYPE; ANIMAL; C57BL MOUSE; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HEART FAILURE; HEART VENTRICLE; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; TRANSGENIC MOUSE;

ALLELES; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GENOTYPE; HAPTOGLOBINS; HEART FAILURE; HEART VENTRICLES; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 67650086564     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-8-29     Document Type: Article

References (22)

1. Grundy SM Benjamin IJ Burke GL Chait A Eckel RH Howard BV Mitch W Smith SCJ Sowers JR Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association Circulation 1999, 100:1134-1146. 10477542
2. Hayden JM Reaven PD Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors Curr Opin Lipidol 2000, 11:519-528. 10.1097/00041433-200010000-00010 11048895
3. Stratton IM Adler AI Neil HA Matthews DR Manley SE Cull CA Hadden D Turner RC Holman RR Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study BMJ 2000, 321:405-412. 27454 10938048 10.1136/ bmj.321.7258.405
4. Chowdhury TA Kumar S Barnett AH Bain SC Nephropathy in type 1 diabetes: the role of genetic factors Diabet Med 1995, 12:1059-1067. 8750215
5. Ruiz J Diabetes mellitus and the late complications: Influence of the genetic factors Diabetes Metab 1997, 23(Suppl 2):57-63. 9105785
6. Marre M Genetics and the prediction of complications in type 1 diabetes Diabetes Care 1999, 22(Suppl 2):B53-B58. 10097900
7. Earle K Walker J Hill C Viberti G Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy N Engl J Med 1992, 326:673-677. 1736105
8. Tarnow L Rossing P Nielsen FS Fagerudd JA Poirier O Parving HH Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy Diabetes Care 2000, 23:30-33. 10.2337/diacare.23.1.30 10857964
9. Imperatore G Hanson RL Pettitt DJ Kobes S Bennett PH Knowler WC Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group Diabetes 1998, 47:821-830. 10.2337/diabetes.47.5.821 9588456
10. Levy AP Roguin A Hochberg I Herer P Marsh S Nakhoul FM Skorecki K Haptoglobin phenotype and vascular complications in patients with diabetes N Engl J Med 2000, 343:969-970. 10.1056/NEJM200009283431313 11012324
11. Levy AP Hochberg I Jablonski K Resnick HE Lee ET Best L Howard BV Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study J Am Coll Cardiol 2002, 40:1984-1990. 10.1016/S0735-1097(02)02534-2 12475459
12. Polonovski M Jayle MF Existance dans le plasma sanguin d'une substance activant l'action peroxidasque de l'hemoglobin Comp Rend Soc de Biol 1938, 129:457-460.
13. Kristiansen M Graversen JH Jacobsen C Sonne O Hoffman HJ Law SK Moestrup SK Identification of the haemoglobin scavenger receptor Nature 2001, 409:198-201. 10.1038/35051594 11196644
14. Graversen JH Madsen M Moestrup SK CD163: A signal receptor scavenging haptoglobin-hemoglobin complexes from plasma Int J Biochem Cell Biol 2002, 34:309-314. 10.1016/S1357-2725(01)00144-3 11854028
15. Roguin A Koch W Kastrati A Aronson D Schomig A Levy AP Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes Diabetes Care 2003, 26(9):2628-31. 10.2337/ diacare.26.9.2628 12941730
16. Suleiman M Aaronson D Asleh R Kapeliovich MR Roguin A Meisel SR Shochat M Sulieman A Reisner SA Markiewicz W Hammerman H Lotan R Levy NS Levy AP Haptoglobin phenotype predicts 30 day mortality and heart failure in patients with diabetes and acute myocardial infarction Diabetes 2005, 54:2802-2806. 10.2337/diabetes.54.9.2802 16123372
17. Milman U Blum S Shapira C Aronson D Miller RL Anbinder Y Alshiek J Bennett L Kostenko M Landau M Keidar S Levy Y Khemlin A Radan A Levy AP Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: A prospective double-blinded clinical trial Arterioscler Thromb Vasc Biol 2008, 28(2):341-7. 10.1161/ ATVBAHA.107.153965 18032779
18. Bowman BH Kurosky A Haptoglobin: The evolutionary product of duplication, unequal crossing over, and point mutation Adv Hum Genet 1982, 12:189-261. 6751044
19. Levy AP Levy JE Kalet-Litman S Miller-Lotan R Levy NS Asaf R Guetta J Yang C Purushothaman KR Fuster V Moreno PR Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque Arterioscler Thromb Vasc Biol 2007, 27(1):134-40. 10.1161/01.ATV.0000251020.24399.a2 17068284
20. Blum S Asaf R Guetta J Miller-Lotan R Asleh R Kremer R Levy NS Berger FG Aronson D Fu X Zhang R Hazen SL Levy AP Haptoglobin genotype determines myocardial infarct size in diabetic mice J Am Coll Cardiol 2007, 49(1):82-7. 10.1016/j.jacc.2006.08.044 17207726
21. De Kleijn DP Smeets MB Kemmeren PP Lim SK Van Middelaar BJ Velema E Schoneveld A Pasterkamp G Borst C Acute-phase protein haptoglobin is a cell migration factor involved in arterial restructuring FASEB J 2002, 16:1123-1125. 12039846
22. Lohr NL Warltier DC Chilian WM Weinbrauch D Haptoglobin expression and activity during coronary collateralization Am J Physiol Heart Circ Physiol 2005, 288(3):H1389-1395. 10.1152/ajpheart.00938.2004 15550518